SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike stock is facing significant volatility following earnings results that beat revenue and profit expectations, though investors remain cautious due to guidance on ongoing demand softness in key international markets. The community is sharply divided between those viewing the current valuation as a generational buying opportunity and others skeptical of a turnaround amid intense competitive and macroeconomic pressures.

NIO, Inc. operates as a holding company, which engages in the design, development, manufacture, and sale of smart electric vehicles. It offers its products under the brands NIO, ONVO, and FIREFLY. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Shanghai, China.

NIO Inc - ADR

NIO Inc

NIO is trending as the market digests strong June delivery figures alongside aggressive growth in its premium SUV segment, despite persistent concerns over guidance accuracy and sector-wide volatility. Investors are actively debating the company's long-term profitability and the impact of the ongoing competition with rivals like Li Auto and Xpeng within a saturated Chinese EV landscape.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing significant bearish pressure as investors express frustration over a lack of new enterprise contract catalysts and ongoing concerns regarding cash burn and dilution. Despite community debates over the company's long-term potential in voice and Agentic AI, heavy short interest remains a primary focal point, leaving traders divided between those accumulating at lower price levels and others concerned about the stock's persistent lack of upward momentum.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is surging as investors react to a milestone earnings report that showcased the company's first quarterly profit and significant revenue growth. The community is buzzing over the stock's potential for a short squeeze, fueled by high short interest and anticipation surrounding a major upcoming court verdict against Google.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is seeing renewed investor interest as the software sector undergoes a rotation, fueled by insider buying, strong institutional block orders, and a shifting narrative that enterprise AI will complement rather than disrupt existing platforms. The community is actively discussing a potential rebound as the stock shows technical strength, with many focusing on the upcoming quarterly results and the company's role as a key orchestrator in enterprise AI.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is currently experiencing high volatility following its inclusion in the Russell 1000 index, with investors debating whether the sharp pullback is a technical rebalancing event or a sign of overvaluation. The community remains focused on the company's long-term potential as a critical power infrastructure provider for AI data centers, weighing this against concerns over its negative earnings and rapid price fluctuations.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is seeing significant retail and institutional interest fueled by speculation surrounding a potential buyout, underscored by recent corporate governance changes and the highly anticipated 80th clinical event for its REGAL trial. While community sentiment remains intensely polarized between optimistic long-term bulls anticipating a paradigm shift in cancer treatment and vocal bears questioning trial timelines and clinical endpoints, the discussion is dominated by the strategic positioning of large-scale capital and the implications of the ongoing data monitoring committee's oversight.

General Mills, Inc. engages in the manufacture of food. Its portfolio of brands includes household names like Cheerios, Nature Valley, Blue Buffalo, Häagen-Dazs, Old El Paso, Pillsbury, Betty Crocker, Totino’s, Annie’s, Wanchai Ferry and more. It operates through the following segments: North America Retail, International, North America Pet, and North America Foodservice. The North America Retail segment includes grocery stores, mass merchandisers, membership stores, natural food chains, drug, dollar and discount chains, convenience stores, and e-commerce grocery providers. The International segment refers to the retail and foodservice businesses outside of the US and Canada. The North America Pet segment includes pet food products sold in national pet superstore chains, e-commerce retailers, grocery stores, regional pet store chains, mass merchandisers, and veterinary clinics and hospitals. The North America Foodservice segment offers ready-to-eat cereals, snacks, refrigerated yogurt, frozen meals, unbaked and fully baked frozen dough products, baking mixes, and bakery flour. The company was founded by Cadwallader C. Washburn on June 20, 1928 and is headquartered in Minneapolis, MN.

General Mills, Inc.

General Mills is trending as investors weigh an updated fiscal outlook featuring aggressive cost-cutting targets against broader consumer demand headwinds. The community is actively debating the stock's value as a defensive, high-yield dividend play amidst institutional rotation and ongoing productivity initiatives aimed at restoring long-term growth.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is generating buzz as retail investors watch for a potential short squeeze, fueled by rising borrow fees and speculation that recent robotaxi partnerships with Uber and Nuro could serve as a catalyst for a reversal. Community discussion is split between bullish sentiment regarding the potential for a gamma squeeze to drive the stock higher and bearish concerns over ongoing production challenges, management changes, and the company's long-term path to profitability.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health is seeing significant bullish sentiment driven by the recent commercial launch of the BYOOVIZ biosimilar and strong script growth for the dry eye treatment VEVYE. Community members are increasingly focused on the company's platform expansion and the potential for a massive revenue ramp-up as it strengthens its position in the retina and specialty pharmaceutical markets.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet

Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic...

DRTS Stock Shot Up A Whopping 22% Today – Why A $196.5M Prostate Cancer Deal Got Investors Buzzing

Equity

Alpha Tau signed an agreement with Tolmar to commercialize its lead cancer therapy for prostate cancer in the United States.

DRTS Stock Gets A Pre-Market Boost – Retail Shrug Off Wider Q1 Loss Ahead Of Key Pancreatic Cancer Data Reveal This Week

An extract featuring safety and efficacy results from three studies evaluating its key therapy for pancreatic cancer will be unveiled on Thursday.

Alpha Tau Medical Stock Surges As Interim Brain Tumor Trial Data Sparks Rally

Alpha Tau Medical stock surged after interim glioblastoma data showed complete responses in two patients treated with Alpha DaRT.read more...

DRTS Stock Surges Pre-Market Even As Retail Traders Debate ‘Too Small’ Brain Cancer Trial Data 

The biotech company’s experimental treatment for recurrent glioblastoma resulted in complete responses in 2 of the first 3 patients.

Nasdaq, S&P 500 Futures Dip As Trump-Iran Tensions Lift Crude Oil Prices: Why MU, MRAM, MLTX, DRTS, ASTS Are In Focus

Data from Stocktwits shows that retail traders’ sentiment has remained ‘bullish’ on SPY and QQQ, following last week’s resilience in tech and AI-linked names. 


DRTS Stock Rises Overnight: Early US Brain Cancer Trial Results Expected Today

Last week, Alpha Tau Medical completed enrollment in its ReStart study for recurring skin cancer.

Alpha Tau Medical (NASDAQ:DRTS) Shares Gap Up - Still a Buy?

Alpha Tau Medical (NASDAQ:DRTS) Shares Gap Up - Here's Why...

Alpha Tau Medical (NASDAQ:DRTS) Reaches New 1-Year High - Time to Buy?

Alpha Tau Medical (NASDAQ:DRTS) Hits New 52-Week High - Here's Why...

Alpha Tau Medical (NASDAQ:DRTS) Sees Strong Trading Volume - Here's What Happened

Alpha Tau Medical (NASDAQ:DRTS) Sees Large Volume Increase - Here's Why...

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

Extremely Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$12.58
Prev Close	$11.22
Open	$11.47
Dividend Yield	0.00%
50-Day Moving Average	$9.48
Beta	0.79
Avg. Volume	1.07M
PE Ratio	-19.05

52-Week High	$12.61
52-Week Low	$2.87
Market Capitalization	$1.11B
EPS (Annual)	-$0.529
Price to Book	16.36
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

DRTSALPHA TAU MEDICAL LTD

Latest DRTS News